z-logo
open-access-imgOpen Access
Different kinds of stem cells in the development of SARS-CoV-2 treatments
Author(s) -
Mónica Maribel Mata-Miranda,
Miguel Sánchez-Brito,
Gustavo Jesús Vázquez-Zapién
Publication year - 2021
Publication title -
world journal of stem cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.907
H-Index - 18
ISSN - 1948-0210
DOI - 10.4252/wjsc.v13.i5.439
Subject(s) - induced pluripotent stem cell , covid-19 , regenerative medicine , mesenchymal stem cell , coronavirus , medicine , pandemic , stem cell , neuroscience , disease , intensive care medicine , virology , biology , embryonic stem cell , microbiology and biotechnology , pathology , infectious disease (medical specialty) , gene , biochemistry
On February 11, 2020, the World Health Organization officially announced the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as an emerging recent pandemic illness, which currently has approximately taken the life of two million persons in more than 200 countries. Medical, clinical, and scientific efforts have focused on searching for new prevention and treatment strategies. Regenerative medicine and tissue engineering focused on using stem cells (SCs) have become a promising tool, and the regenerative and immunoregulatory capabilities of mesenchymal SCs (MSCs) and their exosomes have been demonstrated. Moreover, it has been essential to establishing models to reproduce the viral life cycle and mimic the pathology of COVID-19 to understand the virus's behavior. The fields of pluripotent SCs (PSCs), induced PSCs (iPSCs), and artificial iPSCs have been used for this purpose in the development of infection models or organoids. Nevertheless, some inconveniences have been declared in SC use; for example, it has been reported that SARS-CoV-2 enters human cells through the angiotensin-converting enzyme 2 receptor, which is highly expressed in MSCs, so it is important to continue investigating the employment of SCs in COVID-19, taking into consideration their advantages and disadvantages. In this review, we expose the use of different kinds of SCs and their derivatives for studying the SARS-CoV-2 behavior and develop treatments to counter COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here